GCP requirements 2018 - How to Audit Against ICH GCP 2 Addendum to Ensure Compliance

Overview:
It is important GCP Auditors to understand how to audit the changes required by the new ICH GCP R2 Addendum. To consider how audit checklists and procedures should have been updated to ensure the new requirements are met and their organisations are ready for regulatory inspection. The session will also include an update on the proposed further major revision of ICH GCP R2 planned by ICH to start later next year. The new guideline includes a number of "hot" GCP inspection topics which are also covered in a number of other EU and FDA guidelines and documents, such as risk-based approaches for running clinical trials. These new approaches are going to be areas inspectors will be focussing on.
Why should you Attend: This informative session will cover these new requirements for auditing clinical trials, evaluate the changes and understand how these impact on auditors. This will enable you to meet the new international GCP standard to ensure the acceptance of clinical trial data by the regulatory authorities internationally including the European Union (EU), Japan, the United States, Canada and Switzerland.
Areas Covered in the Session:
Understand the new requirements of the updated ICH GCP R2 guideline for auditors
Hear about the future ICH major revision planned
Review the new requirements for what auditors should look for Sponsor Oversight, Risk based quality systems, risk based monitoring, data management, Investigator site audit, the trial master file
Review best practice of these additional new GCP requirements for auditors
Who Will Benefit:
Auditors
QA Professionals
Clinical Research/Clinical Operations
Regulatory Affairs
CRO, Regulatory Authorities
Clinical Trial Personnel
Quality Assurance
All other Professionals who want to know more about the new ICH GCP (R2) guideline
Speaker Profile
Dr. Laura Brown , PhD, MBA, Diploma Clinical Sciences, is an independent QA and training consultant in the pharmaceutical industry. She is a managing director with LB Training and Development Ltd., course director for the M.Sc. in Clinical Research, School of Pharmacy at the University of Cardiff, and course director for M.Sc. Regulatory Affairs, TOPRA. Dr. Brown has 20 years experience running clinical trials and clinical quality assurance in the pharmaceutical industry, and auditing clinical trials internationally. She has held a number of international and senior management QA positions in the pharmaceutical industry including her role as an associate director with a leading GCP audit consultancy.
Event link : http://www.compliance4all.com/control/w_product/~p...
Contact Details:
NetZealous LLC, DBA compliance4All
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com